Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Genetic Tech Spn ADR (GENE)

Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Genetic Tech Spn ADR 60-66 Hanover Street Fitzroy C3 3065 AUS

www.genetype.com Employees: 58 P: 61-3-8412-7000 F: +61 384127040

Description:

Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.

Key Statistics

Overview:

Market Capitalization, $K 3,372
Enterprise Value, $K 3,122
Shares Outstanding, K 4,407
Annual Sales, $ 5,030 K
Annual Net Income, $ -7,880 K
Last Quarter Sales, $ 3,331 K
Last Quarter Net Income, $ -2,502 K
EBIT, $ 0 K
EBITDA, $ -2,710 K
60-Month Beta 1.12
% of Insider Shareholders 6.46%
% of Institutional Shareholders 0.63%
Float, K 4,122
% Float 93.54%
Short Volume Ratio 0.30

Growth:

1-Year Return -77.99%
3-Year Return -94.63%
5-Year Return -93.08%
5-Year Revenue Growth 25,050.00%
5-Year Earnings Growth 68.04%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 10/02/24
Earnings Per Share ttm 0.00
EPS Growth vs. Prev Qtr -18.22%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 12/14/23

GENE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -156.66%
Debt/Equity 0.35
Price/Sales 0.75
Price/Cash Flow N/A
Price/Book 3.09
Book Value/Share 0.25
Interest Coverage -0.65
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar